The Learning Center

Autologous Gene Editing for Sickle Cell Disease and Transfusion Dependent Beta Thalassemia

The Advanced Practice Providers SIG is hosting a webinar on 'Autologous Gene Editing for Sickle Cell Disease and Transfusion Dependent Beta Thalassemia' on Thursday, July 18, at 2 p.m. CDT. This webinar is open to all ASTCT members and non-members. Please note that there is no CME offered for attending this webinar. 

Speaker:

Haydar Frangoul, MD, MS; Program Director, Sarah Cannon Pediatric Hematology/Oncology & Cellular Therapy @TriStar Centennial


Session Learning Objectives:

  • Understand importance of elevated fetal hemoglobin in SCD and TDT
  • Review gene editing technology to induce fetal hemoglobin
  • Review gene therapy patient journey
  • Understand indications for gene editing in SCD and TDT
  • Review the updated results for gene therapy  
  • Understand toxicities related to gene editing therapy

Key:

Complete
Failed
Available
Locked
Webinar Recording
Open to view video.
Open to view video.